Programs that increase access to epinephrine autoinjectors to treat anaphylaxis caused by food allergies, along with training in using them, need to be expanded, according to a review published in Annals of Allergy, Asthma & Immunology.
Expanding access and training would minimize the disparities in care experienced by underrepresented groups and by those who come from a lower socioeconomic background, Ellen W. Daily Stephen, MD, a first year allergy and immunology fellow in the department of internal medicine at Rush University Medical Center in Chicago, and colleagues wrote in the